749
edits
Changes
no edit summary
__NOTOC__
[[File:Glossary Header-left2.png|800px|frameless|left|link=ICRP Glossary]]
{| class="wikitable"
|-
| [[#A|A]] || [[#B|B]] || [[#C|C]]|| [[#D|D]] || [[#E|E]] || [[#F|F]] || [[#G|G]] || [[#H|H]] || [[#I|I]] || [[#J|J]] || [[#K|K]] || [[#L|L]] || [[#M|M]] ||[[#N|N]] || [[#O|O]] || [[#P|P]] || [[#Q|Q]] || [[#R|R]] || [[#S|S]] || [[#T|T]] || [[#U|U]] || [[#V|V]] || [[#W|W]] || [[#X|X]] || [[#Y|Y]] || [[#Z|Z]] || [[#ZZ|...]]
|}
<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2">
=== <big><span id="A">A</span></big> ===
* [[Accelerated fractionationAbsolute risk]]
* [[Acceptance testAccelerated fractionation]]
* [[Access ControlAcceptance test]]
*[[Access control]] * [[Accountability]]
*[[Action Level]]
*[[Active (red) bone marrow]]
*[[Activity median thermodynamic diameter ]]
*[[Acute Exposureexposure]] *Acute radiation sickness (see *[[Acute radiation syndrome]]) *[[Acute radiation syndrome]] *[[Adaptive response]] *[[Additive risk projection model]]
*[[Adventitious]]
*[[Adventitious Sourcesource]]
*[[Aerodynamic diameter ]]
*[[Alpha decay]]
*[[Alveolar-interstitial region]]
*[[Area monitoring]]
*ARS (see [[Acute radiation syndrome]])
*[[Attributable risk]]
*[[Auger transition]]
*[[Authorised Dischargedischarge]]
*[[Authorization]]
*[[Background dose (rate)]]
*[[Backscatter Factor factor]]
*[[Basal cell]]
*[[Baseline disease rates]]
*BAT (see [[Best available techniques]])
*[[Beneficence]]
*[[Benthic]]
*[[Best Available Techniquesavailable techniques]]
*[[Beta-minus decay]]
*[[Bioassay]]
*[[Biomarker]]
*[[Biomedical research volunteer]]
*[[Cardioverter-defibrillator]]
*[[Case–control study]]
*[[Cell death]]
*[[Co-expertise]]
*[[Cohort study]]
*[[Colony]]
=== <big><span id="D">D</span></big> ===
*DD (see [[Doubling dose)]])
*DDREF (see [[Dose and dose-rate effectiveness factor)]])
*[[Decay constant]]
*[[Deontological Ethics]]
*[[Deterministic effect]]
*Detriment (see [[Radiation detriment]])
*[[Detriment-adjusted risk]]
*[[Diastasis]]
*[[Dicentric chromosome]]
*[[Dichotomous]]
*[[Disposal]]
*[[Disposal Facilityfacility]]
*[[DNA damage signalling]]
*[[Dose and dose-rate effectiveness factor)]]
*[[Dose constraint]]
*[[Dose limit]]
*[[Dose Modifying Factormodifying factor]]
*[[Dose per unit intake coefficient]]
*[[Dose rate effectiveness factor]]
*[[Dose-threshold hypothesis]]
*[[Dose-rate effect]]
*[[Dose-threshold]]
*[[Doubling dose]]
=== <big><span id="E">E</span></big> ===
*[[Effect Dose 50 ]]
*[[Effect modifier]]
*[[Effective charge number]]
*[[Electrophysiology]]
*[[Elemental dose]]
*ELR (see *[[Excess lifetime risk]])
*[[Emergency]]
*[[Endogeneous excretion]]
*[[Epigenetic effects]]
*[[Environmental exposure]]
*[[Ethics]]
*[[Excess absolute risk]]
*[[Excess lifetime risk]]
*[[Excess relative risk]]
*[[Excretion rate (instantaneous)]]
*[[Exposure, external or internal]]
*[[Exposure Pathwaypathway]]
*[[Exposure situation]]
*[[Gastrointestinal syndrome]]
*[[Genomic integrity]]
*[[Graded approach]]
*[[Heliosphere]]
*[[Hereditary effect]]
*[[Hierarchical tissues]]
*[[High level waste]]
*[[Homologous recombination]]
*[[Hormones]]
*[[In vivo radiobioassay]]
*[[Incidence]]
*Incidence rate (see [[Incidence]])
*[[Incident]]
*[[Individual-related]]
*[[Induced genomic instability]] *[[Informed Consentconsent]]
*[[Inhalability]]
=== <big><span id="L">L</span></big> ===
*[[Late normal tissue responses]]
*[[Latent time/period or latency interval]]
*[[LD 50/30|LD<sub>50/30</sub>]]
*[[Life span study]]
*[[Lifetime risk]]
*[[Lifetime risk estimate]]
*[[Limitation of dose]]
*[[Lineal energy]]
*[[Linear dose response]]
*[[Linear-non-threshold model]]
*[[Linear-quadratic dose response]]
*LLE (see [[Loss of Life Expectancy]])
*[[Loss of Life Expectancy]]
*[[Low Earth orbit]]
*[[Low dose]]
*[[Low dose rate]]
*[[Low level waste]]
*LSS (see [[Life span study]])
*[[Lymphatic system]]
=== <big><span id="M">M</span></big> ===
*[[Macrophage colony stimulating factor]]
*[[Mitigation]]
*[[Multiplicative risk projection model]]
*[[Multistage carcinogenesis model]]
*[[Multistage tumorigenesis]]
*[[Mutation component]]
*[[Myocardial perfusion]]
*[[Neurovascular syndrome]]
*NHEJ (see [[Non-homologous end joining]])
*[[Nominal risk coefficient]]
*[[Non-homologous end joining]]
*[[Non-maleficence]]
*[[Non-sphericity parameter]]
*[[Non-targeted effects]]
*[[Normal tissue complication probability]]
*[[Nuclear track detectors]]
=== <big><span id="O">O</span></big> ===
*[[Occupational exposure]]
*[[Occupational exposureOncogene]]
*[[Optimisation]]
*[[Platelet-derived growth factor]]
*PLDR (see [[Potentially lethal damage repair]])
*[[Pooled analysis]]
*[[Population risk]]
*[[Potential exposure]]
*[[Potentially lethal damage repair]]
*[[Practical radiological protection culture]]
=== <big><span id="Q">Q</span></big> ===
*[[Qualified expert]]
*[[Qualified expertQuasi-threshold dose]]
=== <big><span id="R">R</span></big> ===
*[[Radiation modifier]]
*[[Radiation risk]]
*[[Radiation safety officer]]
*[[Radiographer]]
*[[Radiological Controlled Areacontrolled area]]
*[[Radiological protection principles]]
*[[Radiosensitivity, cellular]]
*RAP (see [[Reference Animal and Plant]])
*RBE (see [[Relative biological effectiveness]])
*[[Reactive oxygen species]]
*[[Reasonableness]]
*[[Recovery responder]]
*[[Recovery (cellular or tissue)]]
*[[Reference Animal and Plant]]
*[[Reference bioassay function]]
*[[Reference level]]
*REID (see [[Risk of exposure-induced death]])
*[[Rehabilitation of living conditions]]
*[[Relative biological effectiveness]]
*[[Relative life lost]]
*[[Relative risk]]
*[[Relocation]]
*[[Rigidity]]
*[[Ring chromosome]]
*[[Risk]]
*[[Risk coefficient]]
*[[Risk model]]
*[[Risk of exposure-induced death]]
*ROS (see [[Reactive oxygen species]])
*[[Routine monitoring]]
*RR (see [[Relative risk]])
=== <big><span id="S">S</span></big> ===
*[[Senescence]]
*[[Severe deterministic injury]]
*SLDR (see [[Sublethal damage repair]])
*[[Slow repair]]
*[[Solar wind]]
*[[Somatic effect]]
*[[Source term]]
*[[Stenosis]]
*[[Stochastic effect]]
*[[Storage]]
*[[Subcutaneous tissue]]
*[[Sublethal damage repair]]
*[[Substantial radiation dose level]]
*[[Supervised Areaarea]]
*[[Systemic model]]
*[[Target tissue]]
*[[Targeted effects]]
*[[Telangiectasia]]
*[[Tissue equivalent material]]
*[[Tissue reaction]]
*[[Tissue weighting factor]]
*[[Tolerability]]
*[[Transfer compartment]]
*[[Transfer of risk]]
*[[Transfer rate]]
*[[Transforming growth factor]]
*[[Transgenerational effect]]
*[[Translocation]]
*[[Transparency]]
*Transport of risk (see [[Transfer of risk]])
*[[Tumour suppressor gene]]
*[[Trapped particles]]
=== <big><span id="U">U</span></big> ===
*[[Unsealed source]]
=== <big><span id="V">V</span></big> ===
*[[Value judgement]]
*[[Wisdom]]
*w<sub>T</sub> (see [[Tissue weighting factor]])
*w<sub>R</sub> (see [[Radiation weighting factor]])
=== <big><span id="X">X</span></big> ===
=== <big><span id="Z">Z</span></big> ===
=== <big><span id="ZZ">...</span></big> ===
*[[α/β value]]
*α/β ratio (see [[α/β value]])
*[[γH2AX foci]]
<div>